Nerve Repair and Regeneration Market worth $12.64 billion by 2031
DELRAY BEACH, Fla., Sept. 11, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Nerve Repair and Regeneration Market is projected…
Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment
Gilead Bixlenvo drug Courtesy: Gilead The Food and Drug Administration approved a once-daily HIV pill from Gilead that…
HHS plans new FDA leadership roles for technology, drugs
The logo for the Food and Drug Administration is seen ahead of a news conference at the Health…
A scoping review on the mental health harms of LLM-based chatbots
Weizenbaum, J. ELIZA—a computer program for the study of natural language communication between man and machine. Commun. ACM…
Why vaccination rates are falling in the U.S.
A Medical Assistant gives a measles, mumps and rubella, vaccination to a young person at the pediatric office…
Amylyx endocrine drug succeeds in key study for low blood sugar
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
First human trials of designer protein therapies stun US neuroscientists
“Stunned silence.” That’s how Bryan Roth of the University of North Carolina School of Medicine described the…
CVS Health (CVS) earnings Q2 2026
CVS Health on Wednesday blew past second-quarter earnings and revenue estimates and raised its 2026 guidance, as its…
Eli Lilly to offer retatrutide access given earlier to just one patient
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
The VA is critical to winning the biotech race with China
Biotechnology is rapidly becoming a pillar of national power. The nation that can discover, test, and deploy new…
FDA questions the efficacy of Capricor’s Duchenne drug
The Food and Drug Administration said Monday that Capricor Therapeutics’ stem cell treatment for Duchenne muscular dystrophy did…